CRL - Charles River Laboratories - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CRL is currently covered by 20 analysts with an average price target of $166.42. This is a potential upside of $25.45 (18.05%) from yesterday's end of day stock price of $140.97.

Charles River Laboratories's activity chart (see below) currently has 202 price targets and 206 ratings on display. The stock rating distribution of CRL is 45.07% BUY, 52.11% HOLD and 2.82% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 64.38% with an average time for these price targets to be met of 85.52 days.

Highest price target for CRL is $240, Lowest price target is $140, average price target is $206.94.

Most recent stock forecast was given by LUKE SERGOTT from BARCLAYS on 08-May-2025. First documented stock forecast 30-Oct-2014.

Currently out of the existing stock ratings of CRL, 32 are a BUY (45.07%), 37 are a HOLD (52.11%), 2 are a SELL (2.82%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$155

$16.21 (11.68%)

$145

9 days ago
(08-May-2025)

4/6 (66.67%)

$13.64 (9.65%)

40

Hold

$170

$31.21 (22.49%)

$190

9 days ago
(08-May-2025)

2/6 (33.33%)

$28.64 (20.26%)

8

Hold

$140

$1.21 (0.87%)

$173

9 days ago
(08-May-2025)

12/15 (80%)

$-1.36 (-0.96%)

62

Hold

$155

$16.21 (11.68%)

$210

1 months 8 days ago
(09-Apr-2025)

2/3 (66.67%)

$15.93 (11.45%)

69

Buy

$170

$31.21 (22.49%)

$190

1 months 26 days ago
(21-Mar-2025)

0/4 (0%)

$2.72 (1.63%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CRL (Charles River Laboratories) average time for price targets to be met?

On average it took 85.52 days on average for the stock forecasts to be realized with a an average price target met ratio 64.38

Which analyst has the current highest performing score on CRL (Charles River Laboratories) with a proven track record?

DAN LEONARD

Which analyst has the most public recommendations on CRL (Charles River Laboratories)?

Dan Leonard has 16 price targets and 8 ratings on CRL

Which analyst is the currently most bullish on CRL (Charles River Laboratories)?

Robert Jones with highest potential upside - $190.21

Which analyst is the currently most reserved on CRL (Charles River Laboratories)?

Sandy Draper with lowest potential downside - -$0

Charles River Laboratories in the News

What Is Charles River Laboratories International, Inc.'s (NYSE:CRL) Share Price Doing?

Charles River Laboratories International, Inc. (NYSE:CRL), is not the largest company out there, but it received a lot of attention from a substantial price increase on the NYSE over the last few months. While good news for shareholders, the company has traded much higher in the past year. As a mid-cap stock with high coverage...

Charles River Laboratories International Inc (CRL) Q1 2025 Earnings Call Highlights: Navigating ...

Revenue: $984.2 million in Q1 2025, a 2.7% decrease year-over-year. Organic Revenue Decline: 1.8% decrease driven by low single-digit declines in all business segments. Operating Margin: 19.1%, an increase of 60 basis points year-over-year. Earnings Per Share (EPS): $2.34, a 3.1% increase from Q1 2024. DSA Revenue: $592.6 million, a 1.4% organic decrease. RMS Revenue:...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?